Amphastar Pharmaceuticals, Inc. — Director's Dealing 2019

Mar 2, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2019-03-01

Reporting Person: Shandell Jason B. (Director, President and General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-03-01	Common Stock	M	7500	$20.26	Acquired	175818	Direct
2019-03-01	Common Stock	S	7500	$24.99	Disposed	168318	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-03-01	Employee Stock Option (right to buy)	$20.26	M	7500	Disposed	2019-08-02	Common Stock (7500)	Direct

Footnotes

F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2018.

F2: Shares subject to the option are fully vested and immediately exercisable.